Ergoferon tablets №20

Description

Ergoferon Composition
active ingredients: 1 tablet contains antibodies to human gamma interferon affinity purified: a mixture of homeopathic dilutions С12, СЗ0 and С50 – 6 mg of antibodies to histamine affinity purified: a mixture of homeopathic dilutions С12, СЗ0 and С50 – 6 mg of antibodies to CD4 affinity purified: a mixture of homeopathic dilutions С12, СЗ0 and С50 – 6 mg;

excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.

Ergoferon Dosage form
Pills.

Basic physical and chemical properties: tablets of a flat-cylindrical shape, with a score and a chamfer, from white to almost white.

One flat side has a stroke, the other flat side has the inscription ERGOFERON.

Pharmacological group
Homeopathic medicine.

Pharmacological properties
Antiviral, antihistamine.

The spectrum of pharmacological activity of the drug includes antiviral, immunomodulatory, antihistamine, anti-inflammatory action.

Experimentally and clinically proved the effectiveness of the use of drug components in the treatment of such viral infectious diseases: influenza A and influenza B, acute respiratory viral infections (caused by parainfluenza viruses, adenoviruses, respiratory syncytial virus, coronaviruses), herpesvirus infections (labial herpes, ophthalmic herpes, genital , herpes zoster, chickenpox, infectious mononucleosis), acute intestinal infections of viral etiology (caused by caliciviruses, coronaviruses, rotaviruses, enteroviruses), enteroviral and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis.

The drug is used in the complex therapy of bacterial infections [pseudotuberculosis, whooping cough, yersiniosis, pneumonia of various etiologies, including atypical pathogens (M. pneumoniae, C. pneumoniae, Legionella spp.)], For the prevention of bacterial complications of viral infections, superinfection. The use of the drug in the pre- and post-vaccination period increases the effectiveness of vaccination, provides nonspecific prevention of acute respiratory viral infections and influenza at the time of the formation of post-vaccination immunity. The drug has a prophylactic efficacy against ARVI of non-cryogenic etiology, prevents the development of intercurrent diseases in the post-vaccination period.

Ergoferon Indications
Prevention and treatment:

influenza A and B;
acute respiratory viral infections caused by parainfluenza virus, adenovirus, respiratory syncytial virus, coronavirus;
herpesvirus infections (labial herpes, ophthalmic herpes, genital herpes, chickenpox, herpes zoster, infectious mononucleosis);
acute intestinal infections of viral etiology (caused by calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses);
enterovirus and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis.
Application in the complex therapy of bacterial infections [pseudotuberculosis, whooping cough, yersiniosis, pneumonia of various etiologies, including those caused by atypical pathogens (M. pneumoniae, C. pneumoniae, Legionella spp.)]; prevention of bacterial complications of viral infections, superinfection.

Contraindications
Hypersensitivity to the components of the drug.

Interaction with other medicinal products and other forms of interaction
No cases of interaction with other drugs have been identified.